ToxSci Advance Access published online on June 23, 2005
Toxicological Sciences, doi:10.1093/toxsci/kfi240
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 The Dow Chemical Company, TERC, Midland, Michigan
* To whom correspondence should be addressed.
Received May 5, 2005
Accepted June 20, 2005
Forum
Workshop Proceedings: Managing Conflict of Interest in Science. A Little Consensus and A Lot of Controversy
2 Institute of Neurotoxicology and Neurological Disorders, Seattle, Washington
3 Page One Editorial Services, Boulder, Colorado
4 Georgetown University, Kennedy Institute of Ethics, Washington, District of Columbia
5 Oxford University Press, Bethesda, Maryland
6 Department of Health and Human Services, Office of Human Research Protection, Rockville, Maryland
7 Center for Science in the Public Interest, Washington, District of Columbia
8 The Dow Chemical Company, TERC, Washington, District of Columbia
Jacques P. Maurissen, E-mail: jpjm{at}dow.com
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
L. Claxton A review of conflict of interest, competing interest, and bias for toxicologists Toxicology and Industrial Health, November 1, 2007; 23(10): 557 - 571. [Abstract] [PDF] |
||||
